The Oncology Institute, Inc. (TOI) Misses Q4 EPS by 6c

The Oncology Institute, Inc. (NASDAQ: TOI) reported Q4 EPS of ($0.14), $0.06 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $100.27 million versus the consensus estimate of $109.15 million.

For earnings history and earnings-related data on The Oncology Institute, Inc. (TOI) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• FibroBiologics reports cartilage repair in animal study of joint therapy
• SEALSQ partners with Palm Technologies for India quantum security